Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Cancer Trials Ireland"
Count: 82
Selected: 0
NCT03698201Blood Biomarker Signature in Glioma
NCT05123131Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
NCT06024824Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)
NCT05518110PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
NCT05710666Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
NCT03869762Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.
NCT03153280Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer
NCT04042051Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
NCT03162003Irish Programme for Stratified Prostate Cancer Therapy
NCT02764086INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
NCT02225704Radium-223 in Combination With Enzalutamide
NCT02160353Neo-adjuvant Abiraterone Prostate Study
NCT02151019Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer
NCT02050997Plasma Biomarkers P-DAC, V1
NCT02050750TAILORx Tissue Bank
NCT02050737Plasma Biomarkers C-RAC, ICORG 12-27, V1
NCT01840293Breast Cancer Proteomics and Molecular Heterogeneity
NCT01726309Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
NCT01722851Circulating miRNAs.
NCT01526369A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
NCT01164150Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
NCT00951535A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
NCT00812669CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
NCT008027113-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer
NCT01726322Ovarian Reserve in Premenopausal Breast Cancer
NCT01722890CharactHer. ICORG 12-09, V3
NCT04667663CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
NCT03699111Identification of New Patient Stratification Tools in MSS RAS mt mCRC
NCT01726452NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
NCT02705859Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)
NCT04375904'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)
NCT03843346The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
NCT01566747Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5
NCT04617067Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer
NCT01840306Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer
NCT00955435Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
NCT02177110A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma
NCT01160705Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2
NCT04581070The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic"
NCT02219178Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
NCT00911716TC Avastin. ICORG 08-10, V6
NCT00974168Spinal Cord Compression Re-Treat Study
NCT01485926A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.
NCT00809211Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT02836392CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey
NCT00974610Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
NCT00958321Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35
NCT01176487Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34
NCT00955175Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09